CSat Investment Advisory’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
$38K Buy
173
+5
+3% +$1K 0.03% 260
2020
Q4
$29K Sell
168
-313
-65% -$54.1K 0.03% 269
2020
Q3
$78K Buy
481
+32
+7% +$5.07K 0.01% 557
2020
Q2
$64K Buy
449
+52
+13% +$7.19K 0.01% 630
2020
Q1
$44K Buy
397
+22
+6% +$3.17K 0.01% 558
2019
Q4
$55K Buy
375
+71
+23% +$10.3K 0.01% 601
2019
Q3
$44K Buy
304
+7
+2% +$1.02K 0.01% 598
2019
Q2
$45K Buy
297
+138
+87% +$19.3K 0.02% 588
2019
Q1
$21K Buy
159
+4
+3% +$493 0.01% 307
2018
Q4
$17K Buy
155
+71
+85% +$9.51K 0.01% 320
2018
Q3
$13K Buy
84
+28
+50% +$4.26K 0.01% 318
2018
Q2
$9K Buy
+56
New +$8.45K ﹤0.01% 373

Other funds holding LH

CSat Investment Advisory's LH Position: Q1 2021 in Review

CSat Investment Advisory increased its Labcorp (LH) stake by 3% in Q1 2021, buying an estimated $1K and bringing the position to 173 shares worth $38K. The position accounts for 0.03% of the portfolio, ranked #260.

CSat Investment Advisory first reported a position in LH in Q2 2018 and has held it in 12 quarters since. The position peaked at $78K in Q3 2020. 921 funds tracked by Wall St. Rank hold LH as of Q1 2021.

  • CSat Investment Advisory held 173 shares of Labcorp worth $38K as of Q1 2021.
  • CSat Investment Advisory bought 5 Labcorp shares in Q1 2021, an estimated $1K.
  • Labcorp made up 0.03% of CSat Investment Advisory's portfolio in Q1 2021, its #260 holding.
  • CSat Investment Advisory first reported a position in Labcorp in Q2 2018 and has held it in 12 quarters since.
  • CSat Investment Advisory's Labcorp position peaked at $78K in Q3 2020.
  • 921 funds tracked by Wall St. Rank held Labcorp as of Q1 2021.

Based on CSat Investment Advisory's 13F filing for Q1 2021, filed 13 May 2021.